C1s-INH-248

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameC1s-INH-248
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionComplement C1s inhibitors
TargetsComplement C1s
Therapy Area/IndicationsIschemiaReperfusion Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBasf Pharmachemikalien Gmbh & Co Kg
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBasf Pharmachemikalien Gmbh & Co Kg
Active IndicationsN/A
Inactive IndicationsIschemiaReperfusion Injury

Other Information

ATC CodeN/A
Related LinksN/A